位置:首页 > 蛋白库 > HMR1_PONPY
HMR1_PONPY
ID   HMR1_PONPY              Reviewed;         340 AA.
AC   Q9BD50; Q95M21; Q9BD49;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 101.
DE   RecName: Full=Major histocompatibility complex class I-related gene protein;
DE   AltName: Full=MHC class I-related gene protein;
DE   Flags: Precursor;
GN   Name=MR1;
OS   Pongo pygmaeus (Bornean orangutan).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Pongo.
OX   NCBI_TaxID=9600;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=11797097; DOI=10.1007/s00251-001-0380-1;
RA   Parra-Cuadrado J.F., del Moral M.G., Garcia-Pavia P., Setien F.,
RA   Martinez-Naves E.;
RT   "Characterization of the MHC class I-related MR1 locus in nonhuman
RT   primates.";
RL   Immunogenetics 53:643-648(2001).
CC   -!- FUNCTION: Antigen-presenting molecule specialized in displaying
CC       microbial pyrimidine-based metabolites to alpha-beta T cell receptors
CC       (TCR) on innate-type mucosal-associated invariant T (MAIT) cells. In
CC       complex with B2M preferentially presents riboflavin-derived metabolites
CC       to semi-invariant TCRs on MAIT cells, guiding immune surveillance of
CC       the microbial metabolome at mucosal epithelial barriers (By
CC       similarity). Signature pyrimidine-based microbial antigens are
CC       generated via non-enzymatic condensation of metabolite intermediates of
CC       the riboflavin pathway with by-products arising from other metabolic
CC       pathways such as glycolysis. Typical potent antigenic metabolites are
CC       5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU) and 5-(2-
CC       oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU), products of
CC       condensation of 5-amino-6-D-ribityaminouracil (5-A-RU) with glyoxal or
CC       methylglyoxal by-products, respectively (By similarity). May present
CC       microbial antigens to various MAIT cell subsets, providing for unique
CC       recognition of diverse microbes, including pathogens that do not
CC       synthesize riboflavin. Upon antigen recognition, elicits rapid innate-
CC       type MAIT cell activation to eliminate pathogenic microbes by directly
CC       killing infected cells (By similarity). During T cell development,
CC       drives thymic selection and post-thymic terminal differentiation of
CC       MAIT cells in a process dependent on commensal microflora (By
CC       similarity). Acts as an immune sensor of cancer cell metabolome. May
CC       present a tumor-specific or -associated metabolite essential for cancer
CC       cell survival to a pan-cancer TCR on a non-MAIT CD8-positive T cell
CC       clone, triggering T cell-mediated killing of a wide range of cancer
CC       cell types (By similarity). {ECO:0000250|UniProtKB:Q8HWB0,
CC       ECO:0000250|UniProtKB:Q95460}.
CC   -!- SUBUNIT: Heterotrimer that consists of MR1, B2M and a metabolite
CC       antigen. Forms reversible covalent Schiff base complexes with the
CC       microbial metabolite, which serves as a molecular switch triggering
CC       complete folding, stable association with B2M and translocation of the
CC       ternary complex from endoplasmic reticulum to the plasma membrane. On
CC       antigen-presenting cells, the ternary complex interacts with TCR on
CC       CD8-positive T cells. The molecular machinery involved in antigen
CC       processing remains unknown, but appears to be TAP1-TAP2 and proteasome-
CC       independent. Structurally, MR1-B2M heterodimer adopts a topology
CC       similar to classical MHC class I molecules, with alpha-1 and alpha-2
CC       domains of MR1 forming the antigen-binding cleft composed of two alpha-
CC       helices resting on a floor of 7-stranded anti-parallel beta-pleated
CC       sheet. The ribityl moiety of pyrimidine-based antigens is recognized by
CC       Tyr-95 residue in the CDR3 alpha loop of the invariant TRAV1-2 TCR.
CC       {ECO:0000250|UniProtKB:Q95460}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q95460};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q95460}.
CC       Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q95460}; Single-
CC       pass type I membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q95460}; Single-pass type I membrane protein
CC       {ECO:0000255}. Early endosome membrane {ECO:0000250|UniProtKB:Q95460};
CC       Single-pass type I membrane protein {ECO:0000255}. Late endosome
CC       membrane {ECO:0000250|UniProtKB:Q95460}; Single-pass type I membrane
CC       protein {ECO:0000255}. Note=In the absence of antigen remains within
CC       the endoplasmic reticulum where it acts as a metabolite sensor. Antigen
CC       binding triggers trafficking of the ternary complex to the plasma
CC       membrane. After presentation, most of these complexes are rapidly
CC       internalized and degraded via endocytosis. A small subset recycles via
CC       endosomes back to the plasma membrane and may thus acquire and present
CC       new antigens that do not efficiently reach the endoplasmic reticulum.
CC       {ECO:0000250|UniProtKB:Q95460}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=MR1;
CC         IsoId=Q9BD50-1; Sequence=Displayed;
CC       Name=2; Synonyms=MR1B2;
CC         IsoId=Q9BD50-2; Sequence=VSP_034761;
CC   -!- DOMAIN: The alpha-1 domain is a structural part of antigen-binding
CC       cleft. {ECO:0000250|UniProtKB:Q95460}.
CC   -!- DOMAIN: The alpha-2 domain is a structural part of antigen-binding
CC       cleft. {ECO:0000250|UniProtKB:Q95460}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q95460}.
CC   -!- MISCELLANEOUS: MR1 is detected in an open versus folded conformation.
CC       Only the folded MR1 conformer activates MAIT cells (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ271828; CAC28215.1; -; mRNA.
DR   EMBL; AJ271829; CAC28216.1; -; mRNA.
DR   EMBL; AJ315656; CAC42232.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q9BD50; -.
DR   SMR; Q9BD50; -.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Endoplasmic reticulum;
KW   Endosome; Glycoprotein; Golgi apparatus; Immunity; Immunoglobulin domain;
KW   Innate immunity; Membrane; MHC I; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..340
FT                   /note="Major histocompatibility complex class I-related
FT                   gene protein"
FT                   /id="PRO_0000344445"
FT   TOPO_DOM        23..302
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        303..323
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        324..340
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          203..294
FT                   /note="Ig-like C1-type"
FT   REGION          23..109
FT                   /note="Alpha-1"
FT                   /evidence="ECO:0000250"
FT   REGION          110..201
FT                   /note="Alpha-2"
FT                   /evidence="ECO:0000250"
FT   REGION          202..293
FT                   /note="Alpha-3"
FT                   /evidence="ECO:0000250"
FT   REGION          294..302
FT                   /note="Connecting peptide"
FT                   /evidence="ECO:0000250"
FT   BINDING         31
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         31
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         46
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         46
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         65
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /note="covalent"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         65
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /note="covalent"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         116
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         116
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         174
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         174
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         175
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         175
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   CARBOHYD        107
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        120..183
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        222..278
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         203..294
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11797097"
FT                   /id="VSP_034761"
FT   CONFLICT        63
FT                   /note="Q -> R (in Ref. 1; CAC42232)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        163
FT                   /note="R -> Q (in Ref. 1; CAC42232)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        173
FT                   /note="Q -> L (in Ref. 1; CAC42232)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   340 AA;  39375 MW;  A893952B78725F17 CRC64;
     MGELMAFLLP LIIVLMVKHS NSRTHSLRYF RLGVSDPIRG VPEFISVGYV DSHPITTYDS
     VTQQKEPRAP WMAENLAPDH WERYTQLLRG WQQMFKVELK RLQRHYNHSG SHTYQRMIGC
     ELLEDGSTTG FLQYAYDGQD FLIFNKDTLS WLAVDNVAHT IKRAWEANQH ELQYQKNWLE
     EECIAWLKRF LEYGKDTLQR TEPPLVRVNR KETFPGVTTL FCKAHGFYPP EIYMTWMKNG
     EEIVQEMDYG DILPSGDGTY QTWASFELDP QSSNLYSCHV EHCGVHMVLQ VPQESEAIPL
     VMKAVSGSIV FVIVLTGVGV LVWRRRPREQ NGAVYLPTPD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024